# Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes

> **NCT05003908** · PHASE1 · TERMINATED · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 2 (actual)

## Conditions studied

- Diabetes

## Interventions

- **BIOLOGICAL:** AlloRx

## Key facts

- **NCT ID:** NCT05003908
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-06
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-04-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Due to lack of efficacy
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05003908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05003908, "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05003908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*